Bone cancer is a rare group of cancers that can develop within the bone. Treatment depends on the type of bone cancer, its location and size, stage, grade and the overall health of the patient. At Precision Oncology Clinic, treatment planning is tailored to the individual diagnosis and may involve surgery, chemotherapy, radiation therapy or other specialised treatments when appropriate.
Bone cancer occurs when abnormal cells develop within the bone and grow in an uncontrolled manner. Primary bone cancers begin in the bone itself and are different from cancers that start in another organ and later spread to the bones.
Bone metastases are much more common than primary bone cancers. Therefore, determining whether a tumour originated in the bone or represents cancer that has spread from another part of the body is an important part of diagnosis and treatment planning.
Because bone cancers are uncommon and include several different tumour types, treatment needs to be based on an accurate pathology diagnosis, appropriate imaging and staging.
Not every bone tumour is cancer. There are many benign bone tumours and other non-cancerous conditions that can cause pain, swelling or an abnormality on an X-ray. Further evaluation is needed to determine the cause.
The distinction between primary bone cancer and bone metastasis is important because the treatment strategy can be very different.
Primary bone cancer begins in the cells or tissues of the bone. Examples include osteosarcoma, Ewing sarcoma and chondrosarcoma.
Secondary bone cancer occurs when cancer that began in another organ spreads to the bone. Breast, prostate, lung, kidney and thyroid cancers are among the cancers that can spread to bone.
Primary bone cancers are not a single disease. Different types arise from different tissues within the bone and can behave differently. The exact diagnosis is therefore important before treatment begins.
Osteosarcoma is a malignant bone tumour in which the cancer cells produce abnormal bone tissue. It commonly develops in the long bones, particularly around the knee, although it can occur in other locations.
Ewing sarcoma is a rare cancer that can develop in bone or soft tissue. It occurs more frequently in children, adolescents and young adults, although it can occur at other ages.
Chondrosarcoma develops from cartilage-producing cells and commonly occurs in adults. It can develop in areas such as the pelvis, ribs or long bones.
Several other uncommon malignant bone tumours exist. Their diagnosis and treatment can differ considerably, making specialist pathology assessment important.
Bone tumours involving the spine or pelvis can be particularly complex because of their proximity to nerves, blood vessels and important organs.
Some bone cancers are extremely rare and may require additional pathological or molecular testing to establish the diagnosis and guide treatment.
Two tumours located in the same bone may require completely different treatment approaches. The pathology diagnosis, tumour grade, location and stage all contribute to treatment planning.
Different bone cancers have different biological behaviour and responses to treatment.
The affected bone and relationship to nearby nerves, blood vessels and organs influence surgical planning.
Whether the cancer is localised or has spread to other parts of the body affects the overall treatment strategy.
The symptoms of bone cancer can vary depending on the type of tumour, the bone involved and how advanced the disease is. Symptoms may initially be subtle and can sometimes resemble common musculoskeletal conditions.
Persistent or progressively worsening symptoms should be medically evaluated, particularly when they cannot be explained by an injury or do not improve with usual treatment.
Ongoing pain in a bone is one of the symptoms that can occur with a bone tumour. Pain may become more persistent over time and may sometimes be worse at night.
A swelling or noticeable lump may develop near the affected bone, particularly when the tumour has increased in size.
The area around a bone tumour may become tender or painful when pressure is applied.
When a tumour develops near a joint, it may cause stiffness, discomfort or difficulty moving the affected limb.
A weakened bone can occasionally fracture after relatively minor trauma. An unexpected fracture requires appropriate evaluation.
Some people may experience fatigue, fever or unintentional weight loss, although these symptoms are not specific to bone cancer.
Most bone pain and swelling is caused by conditions other than cancer. However, persistent or unexplained symptoms should not be ignored.
These symptoms do not automatically mean bone cancer. Injuries, infections, arthritis and several benign bone conditions can cause similar symptoms. A medical assessment is needed to determine the underlying cause.
There is no single type of pain that confirms bone cancer. However, pain associated with a bone tumour can have certain patterns that warrant further assessment.
Unlike pain that gradually improves after a minor injury, tumour-related pain may persist or progressively increase.
Pain that becomes more frequent or severe over time should be assessed rather than repeatedly treated without identifying its cause.
Some bone tumours can cause pain that is more noticeable at night, although night pain can also occur with many non-cancerous conditions.
Primary bone cancers are uncommon, and in many patients there is no identifiable cause. Certain inherited conditions and previous treatments can, however, increase the risk of developing some types of bone cancer.
Having a risk factor does not mean that a person will develop bone cancer. Conversely, many people diagnosed with bone cancer do not have a known risk factor.
A new persistent symptom should therefore be evaluated based on the clinical situation rather than risk factors alone.
Different types of bone cancer are more common at different ages. Osteosarcoma and Ewing sarcoma, for example, are more frequently diagnosed in children, adolescents and young adults, while some other bone cancers are more common in adults.
Certain primary bone cancers, including osteosarcoma and Ewing sarcoma, occur more frequently during childhood, adolescence and young adulthood.
Other primary bone cancers, such as chondrosarcoma, are more commonly diagnosed in adults.
In older adults, a suspicious bone lesion may also represent metastatic cancer from another organ rather than a primary bone cancer.
If persistent bone pain, swelling or an unexplained fracture is present, a doctor can determine whether imaging or further evaluation is necessary.
Early assessment does not mean that cancer is suspected in every case. It helps distinguish common musculoskeletal conditions from problems that may require specialist investigation.
Diagnosing bone cancer involves more than identifying an abnormality on an X-ray or scan. Doctors need to establish what the lesion is, determine whether it is a primary bone tumour or cancer that has spread from another organ, and understand its extent before treatment is planned.
The diagnostic process may include a clinical examination, imaging tests, blood tests, biopsy and specialist pathology review. The exact combination of investigations depends on the patient's symptoms and the suspected type and location of the tumour.
A suspicious bone lesion should be evaluated systematically. Imaging and biopsy are interpreted together rather than relying on a single test to establish the diagnosis.
The doctor evaluates pain, swelling, movement, duration of symptoms and relevant medical history.
X-ray or other appropriate imaging may identify an abnormal area within the bone.
MRI, CT or other imaging may be used to define the tumour and assess the rest of the body.
A carefully planned biopsy provides tissue for pathological examination and confirmation of the tumour type.
Different imaging tests answer different clinical questions. Doctors select them according to the suspected tumour, its location and the information required for treatment planning.
An X-ray is often one of the first investigations when a bone tumour is suspected. It can show changes in bone structure, destruction or abnormal bone formation.
MRI provides detailed images of bone and surrounding soft tissues. It can help determine the local extent of a tumour and its relationship with nearby muscles, nerves and blood vessels.
CT can provide detailed information about bone anatomy and may also be used to evaluate the chest or other areas for possible spread.
In selected situations, PET-CT may help evaluate metabolic activity and look for disease elsewhere in the body.
A bone scan can identify areas of increased bone activity and may be useful in selected cases when assessing the skeleton.
Additional imaging may be recommended depending on the tumour's location, symptoms and findings from earlier tests.
There is no single scan that is appropriate for every patient. Imaging is selected according to the clinical question being addressed.
| Investigation | Main Purpose | Typical Role |
|---|---|---|
| X-ray | Evaluates bone structure and identifies suspicious abnormalities | Often part of initial assessment |
| MRI | Defines local tumour extent and surrounding soft tissues | Important for local treatment planning |
| CT | Provides detailed cross-sectional anatomy and can assess distant sites such as the lungs | Staging and treatment planning in selected cases |
| PET-CT | Evaluates areas of increased metabolic activity | Selected staging and treatment assessment |
| Bone Scan | Detects areas of increased bone activity | Selected evaluation of skeletal involvement |
Imaging can strongly suggest a bone tumour, but a biopsy is generally required to establish the exact diagnosis before definitive treatment.
During a biopsy, a sample of tissue is removed from the suspicious area and examined by a pathologist. The pathology report helps determine the type of tumour and provides information that is essential for treatment planning.
A bone tumour biopsy should be planned carefully by a team familiar with the eventual surgical approach.
The appropriate method depends on the tumour's location, accessibility and the information required for diagnosis.
Avoid having an unexplained bone tumour removed without appropriate diagnostic planning. When sarcoma or another malignant bone tumour is suspected, biopsy and surgery should be coordinated so that the procedure does not compromise definitive treatment.
Specialist pathology is particularly important in bone cancer because different tumour types can appear similar clinically or on imaging but require different treatments.
Pathology helps identify the specific type of bone cancer, such as osteosarcoma, Ewing sarcoma or chondrosarcoma.
Where applicable, pathological assessment provides information about tumour grade and biological behaviour.
Additional laboratory tests may help distinguish between different tumour types when the diagnosis is not clear from morphology alone.
Selected tumours may require molecular or genetic testing to confirm a diagnosis or identify clinically relevant alterations.
Complex or uncommon bone tumours may benefit from review by a pathologist with experience in musculoskeletal or sarcoma pathology.
The final pathology diagnosis is combined with imaging and staging information to determine the most appropriate treatment strategy.
Bone pain or an abnormal area on imaging does not necessarily indicate cancer. Several benign or non-cancerous conditions can produce similar findings.
The appearance of a bone lesion on imaging must be interpreted alongside symptoms, age, location and other clinical findings.
When imaging is suspicious, biopsy and pathology may be necessary to establish what the lesion represents.
Once bone cancer has been confirmed, doctors need to determine how far the disease has developed. This process is called staging. Staging helps the oncology team understand whether the cancer is confined to the original bone or has spread to other parts of the body.
The stage is considered together with the tumour type, grade, location and other pathological findings when developing a treatment plan.
Staging is not based on one scan alone. It may involve imaging of the primary tumour, assessment of the lungs and other parts of the body, pathology findings and the characteristics of the specific bone cancer.
The exact staging system varies according to the type of bone cancer. Several important characteristics are considered when evaluating the disease.
The size and local extent of the tumour can influence the classification of the disease and the feasibility of surgery.
For many bone sarcomas, the grade provides information about how abnormal the tumour cells appear and how aggressively the tumour may behave.
Imaging helps determine whether the tumour extends into surrounding soft tissues or involves important nearby structures.
Lymph-node involvement is uncommon in many primary bone sarcomas but may be relevant for particular tumour types.
The presence or absence of distant metastases, particularly in the lungs or other bones, is an important part of assessment.
Different bone cancers have different staging systems and patterns of spread, so the pathological diagnosis matters.
Localised bone cancer means the tumour has not been found to have spread to distant organs. Treatment may focus on controlling the primary tumour and reducing the risk of recurrence.
Metastatic bone cancer has spread to distant parts of the body. Treatment depends on the original tumour type, location and number of metastatic sites, overall health and previous treatment.
Treatment is not determined by the stage alone. The oncology team considers the complete clinical picture before recommending a treatment strategy.
Osteosarcoma, Ewing sarcoma, chondrosarcoma and other rare tumours can require different treatment strategies.
The affected bone and proximity to nerves, blood vessels, joints and other structures can influence surgical options.
The size and local extent of the tumour are important when considering surgery and other local treatments.
Pathological characteristics can influence the expected behaviour of the tumour and treatment recommendations.
In some bone cancers, response to pre-operative treatment can provide useful information for subsequent management.
Age, general health, physical function and other medical conditions are considered when selecting treatments.
Bone cancers can require several areas of specialist expertise. Coordinated decision-making can help integrate pathology, imaging, surgery and systemic or radiation treatment.
Evaluates whether the tumour can be removed safely and how function may be preserved where possible.
Assesses the role of chemotherapy and other systemic treatments according to the tumour type and clinical setting.
Considers radiation therapy when it has a role in local control or symptom management.
Establishes and clarifies the tumour diagnosis and relevant pathological characteristics.
Provides detailed interpretation of imaging for diagnosis, staging and treatment planning.
Rehabilitation, pain management, nutrition and psychosocial support may also form part of comprehensive cancer care.
Every bone cancer is different. A treatment plan that is appropriate for one type of bone cancer may not be appropriate for another. The pathology diagnosis, imaging, stage and individual patient factors should all be considered before treatment begins.
Surgery is an important part of treatment for many localised primary bone cancers. The objective is to remove the tumour with an appropriate margin of healthy tissue while preserving as much useful function as possible.
The type of surgery depends on the tumour's location, size, relationship with nearby structures, tumour subtype, response to other treatments and the patient's overall health.
Surgery is not identical for every bone cancer. A carefully planned operation is based on the pathology, imaging and multidisciplinary treatment plan.
The primary objective is to remove the cancer with an appropriate surgical margin whenever complete removal is possible and clinically appropriate.
When feasible, surgery aims to preserve useful movement and function of the affected limb or body region.
When a substantial portion of bone is removed, reconstruction may be necessary to restore structural stability.
Careful surgical planning and appropriate tumour removal are important components of local disease control.
Rehabilitation and functional recovery are considered as part of the overall treatment journey.
Surgery may be combined with chemotherapy or radiation depending on the tumour type and individual treatment plan.
Limb-sparing surgery, also called limb-salvage surgery, removes the tumour while attempting to preserve the affected limb. Advances in imaging, surgical techniques and reconstruction have made limb preservation possible for many appropriately selected patients.
Limb-sparing surgery is not determined by tumour size alone. MRI and other imaging are used to understand the relationship between the tumour and surrounding structures.
The final decision is based on whether adequate tumour removal and a useful functional outcome can reasonably be achieved.
Removing a bone tumour can leave a defect that needs reconstruction. The reconstruction method depends on the location and size of the defect, the patient's age and other clinical factors.
A specialised implant may be used to replace a segment of bone and restore the structure of a joint or limb.
In selected cases, bone graft material may be used to help reconstruct a bone defect.
Selected patients may be considered for reconstructive techniques using biological bone or other tissue-based approaches.
Amputation is much less common than it was historically, but it may still be necessary in selected situations when adequate cancer removal and a safe, functional limb cannot be achieved with limb-sparing surgery.
Amputation is not recommended simply because a tumour is large. Detailed imaging and multidisciplinary assessment are used to determine whether limb preservation is technically and oncologically appropriate.
When amputation is required, rehabilitation and prosthetic support can form an important part of recovery.
For some bone cancers, particularly certain high-grade tumours, systemic treatment may be given before and/or after surgery. The exact sequence depends on the tumour type and treatment protocol.
Selected patients may receive systemic treatment before surgery to treat microscopic disease and, where applicable, assess tumour response.
The tumour is surgically removed according to the planned oncological approach.
The removed tissue is examined to assess the tumour and response to treatment where relevant.
Additional systemic treatment or other therapy may be recommended according to the diagnosis and treatment plan.
Recovery depends on the type and extent of surgery, the bone involved, reconstruction performed and the patient's general health.
Appropriate pain management is an important part of early recovery and rehabilitation.
A structured rehabilitation programme can help improve strength, mobility and functional independence.
Depending on the operation and reconstruction, weight-bearing may need to be increased gradually under medical guidance.
Follow-up appointments help monitor wound healing, reconstruction and potential complications.
Cancer treatment can be emotionally demanding. Psychological and social support can be valuable during recovery.
Regular follow-up is important for monitoring recovery and checking for recurrence or other treatment-related concerns.
If you have been diagnosed with bone cancer or need specialist guidance after receiving an imaging or pathology report, discuss your diagnosis and treatment options with an oncology specialist.
Book an Oncology ConsultationSystemic treatment uses medicines that travel through the bloodstream to reach cancer cells throughout the body. Its role depends strongly on the type of bone cancer, stage and individual treatment plan.
Some primary bone cancers are particularly sensitive to chemotherapy, while others may have a more limited role for systemic treatment. This is why treatment should be based on the confirmed pathology rather than the location of the tumour alone.
The treatment of bone cancer is highly tumour-specific. Osteosarcoma, Ewing sarcoma, chondrosarcoma and other rare bone tumours can require substantially different treatment approaches.
Chemotherapy uses medicines that target rapidly dividing cancer cells. It has an important role in the treatment of several high-grade bone cancers, particularly osteosarcoma and Ewing sarcoma.
In selected bone cancers, chemotherapy may be given before surgery. This is called neoadjuvant or pre-operative chemotherapy.
Additional chemotherapy may be recommended after surgery to treat microscopic disease and reduce the risk of recurrence, depending on the tumour type and treatment protocol.
Chemotherapy may also be used in selected patients with metastatic or recurrent disease.
The oncology team selects medicines and treatment schedules according to the tumour type and established protocol.
Chemotherapy is commonly delivered in planned cycles with periods of recovery between treatments.
Blood tests, clinical assessment and appropriate imaging help monitor treatment and the patient's tolerance.
The oncology team may adjust treatment according to response, side effects and other clinical factors.
Radiation therapy uses high-energy radiation to damage cancer cells in a specific area. Its role varies according to the type of bone cancer and its location.
Modern radiation planning uses imaging to define the treatment area and limit unnecessary exposure to surrounding healthy tissues.
The radiation oncologist determines the appropriate technique, dose and treatment schedule based on the tumour and the patient's overall treatment plan.
| Treatment | How It Works | Main Role | Use in Bone Cancer |
|---|---|---|---|
| Chemotherapy | Medicines circulate through the body and target cancer cells | Systemic disease control | Important for selected tumour types |
| Radiation Therapy | High-energy radiation targets cancer cells in a specific area | Local disease control or symptom management | Depends on tumour type and clinical situation |
| Surgery | Physically removes the tumour | Local tumour control | Important for many localised primary bone cancers |
Some advanced or uncommon bone and soft-tissue tumours may have specific molecular characteristics that can influence systemic treatment decisions.
Selected tumours may undergo molecular testing to identify genetic or molecular alterations that help clarify the diagnosis or treatment options.
Where an actionable target is identified and an appropriate treatment is available, targeted therapy may be considered in selected clinical situations.
Immunotherapy has a role in selected cancers, but it is not routinely appropriate for every primary bone tumour. Its use depends on the specific diagnosis and clinical evidence.
Side effects vary depending on the medicine, radiation technique, treatment combination and individual patient factors. The oncology team monitors patients throughout treatment.
Tiredness can occur during chemotherapy, radiation therapy or after major surgery.
Some treatments can affect appetite or cause nausea. Medicines are available to help control treatment-related symptoms.
Certain chemotherapy medicines can cause temporary hair loss.
Some systemic treatments can affect blood cell counts, which is why regular blood monitoring may be required.
Radiation therapy can cause skin changes in the treated area, depending on the treatment technique and site.
Specific medicines can have different side effects. Patients should discuss new or persistent symptoms with their oncology team.
The most appropriate treatment is determined by bringing together pathology, imaging, staging and patient-specific factors rather than using a single standard treatment for every case.
Depending on the diagnosis, treatment may involve medical oncology, surgical oncology, radiation oncology, radiology, pathology, rehabilitation and supportive care.
Coordinating these specialties helps the team develop a treatment sequence suited to the patient's individual condition.
A specialist oncology consultation can help you understand your pathology, staging results and available treatment options.
Book an Oncology ConsultationRecovery from bone cancer treatment is a gradual process. Depending on the treatment received, recovery may involve physiotherapy, rehabilitation, nutritional support, pain management and regular oncology follow-up.
Patients who undergo limb-sparing surgery or reconstruction may need a longer period of rehabilitation before returning to their usual activities. Recovery also depends on whether chemotherapy, radiation therapy or other treatments are part of the treatment plan.
Recovery is individual. The pace of rehabilitation should be guided by the treating surgical and oncology team rather than comparing one patient's recovery with another's.
Rehabilitation can help patients regain strength, mobility and independence following surgery. The programme is adapted to the type of operation and reconstruction performed.
Exercises may be introduced gradually to improve strength, flexibility, balance and movement.
Patients may initially require walking aids or other support, depending on the affected limb and surgical procedure.
A structured programme can help rebuild muscle strength and improve functional capacity over time.
When surgery involves a joint or nearby structures, rehabilitation may focus on restoring safe and useful joint movement.
Patients who undergo amputation may require specialised prosthetic assessment and training as part of rehabilitation.
The rehabilitation team can help patients gradually return to personal, household, educational or occupational activities.
Regular follow-up is an important part of bone cancer care even after treatment has been completed. The purpose is to monitor recovery, detect recurrence early and identify any late effects of treatment.
Follow-up visits may include questions about pain, swelling, mobility, general health and new symptoms.
Imaging of the original tumour site and, when appropriate, other areas such as the lungs may be performed according to the follow-up plan.
Patients who have undergone reconstruction may require monitoring of the implant, bone healing or other reconstruction-related issues.
Some chemotherapy, radiation or surgical effects can persist after active treatment and may require ongoing assessment.
Bone cancer can sometimes return after treatment. This is called recurrence. Recurrence may occur at the original tumour site or, depending on the cancer type, at another location in the body.
Local recurrence means the cancer returns in or close to the original tumour area.
Distant recurrence means cancer has returned at another site in the body. The lungs are an important site of metastatic spread for several primary bone sarcomas.
New or persistent symptoms during follow-up should be discussed with the treating team rather than waiting for the next routine appointment.
Persistent or worsening pain around the treated area should be assessed, particularly if it is different from previous symptoms.
A new swelling or lump near the previous tumour site should be evaluated.
A new difficulty with movement, walking or using the affected limb should be reported.
Persistent unexplained symptoms such as significant fatigue, breathlessness or other new health changes should be discussed with the medical team.
Completing active cancer treatment is an important milestone, but long-term health remains an important part of survivorship care.
Anxiety about recurrence, changes in body image, uncertainty about the future and adjustment to physical limitations can affect emotional well-being after cancer treatment.
Counselling, psychological support, family support and cancer support services can be valuable when needed.
Good nutrition supports recovery, muscle strength and overall health. Nutritional needs can change during chemotherapy, radiation therapy and recovery from major surgery.
Adequate protein can support muscle maintenance and tissue recovery, particularly after surgery.
A varied diet containing vegetables, fruits, whole grains, pulses and appropriate protein sources can support general health.
Maintaining adequate fluid intake is important unless the treating team has advised a specific fluid restriction.
A dietitian can help modify food choices when nausea, appetite changes, swallowing problems or other treatment effects make eating difficult.
Many patients gradually return to their daily routines after completing treatment. The timeline varies depending on the cancer, treatment intensity, surgery and individual recovery.
Follow the rehabilitation programme and gradually increase activity according to medical guidance.
Give yourself time to adapt physically and emotionally after completing cancer treatment.
Keep scheduled oncology appointments and recommended investigations.
Work, education, travel and other activities can often be resumed gradually according to recovery and medical advice.
If you have been diagnosed with bone cancer, have completed treatment or are concerned about a possible recurrence, an oncology consultation can help you understand the next steps.
Book an Oncology ConsultationBone cancer treatment requires an individualised approach based on the exact type of cancer, tumour location, stage, imaging, pathology and overall health.
Depending on the diagnosis, treatment may involve surgery, chemotherapy, radiation therapy or a combination of treatments. The treatment plan is developed around the specific needs of the patient.
Bone cancers can be complex and uncommon. Coordinated care allows specialists from different disciplines to contribute to diagnosis, treatment planning, surgery, systemic therapy and rehabilitation.
Helps determine whether the tumour can be safely removed and whether limb-sparing surgery or reconstruction may be appropriate.
Plans chemotherapy and other systemic treatments when they are appropriate for the specific tumour.
Assesses whether radiation therapy has a role based on the tumour type, location and treatment history.
Imaging helps define tumour location, extent and relationship with surrounding structures.
Accurate pathological diagnosis is essential because different bone tumours can require different treatment approaches.
Physiotherapy and rehabilitation can support recovery, mobility and functional independence after treatment.
There is no single treatment that is best for every bone cancer. Treatment depends on the exact tumour type, grade, location, stage and whether it has spread. Surgery, chemotherapy and radiation therapy may be used alone or in combination depending on the diagnosis.
In many appropriately selected patients, limb-sparing surgery may be possible. The decision depends on whether the tumour can be removed adequately while preserving a safe and functional limb. Amputation may still be necessary in selected situations.
No. The role of chemotherapy varies considerably between different types of bone cancer. Some tumours are more responsive to chemotherapy than others, so treatment is determined by the confirmed pathology and clinical stage.
Radiation therapy may be considered for selected bone cancers, particularly when the tumour is sensitive to radiation, cannot be completely removed surgically, recurs or causes symptoms. Its role depends on the specific tumour and previous treatment.
Yes. Some primary bone cancers can spread to other organs. The lungs are an important site of metastatic spread for several bone sarcomas. Staging investigations help determine whether the disease has spread and guide treatment planning.
Diagnosis may involve clinical assessment, imaging such as X-ray, MRI or CT, and a biopsy. Pathological examination of the biopsy is important for establishing the exact tumour diagnosis.
Treatment duration varies significantly according to the type and stage of cancer and the treatments required. Some patients may undergo several cycles of systemic treatment combined with surgery and a period of rehabilitation.
Recurrence is possible with some bone cancers, which is why long-term follow-up is important. Regular clinical assessment and appropriate imaging help monitor for recurrence and treatment-related concerns.
If available, bring pathology or biopsy reports, imaging reports and scans, previous treatment records, blood test results and a list of current medicines. Previous medical records can help the oncology team understand the diagnosis and treatment history.
Because bone cancers can be uncommon and treatment can be complex, discussing the diagnosis and treatment plan with a specialist oncology team can help patients understand their options and make informed decisions.
Previous imaging, biopsy reports, pathology results and treatment records can help the oncology team review your case more effectively.
If you have imaging scans on a CD, USB drive or through an online imaging portal, bring or share them according to the clinic's instructions.
Key takeaway: Bone cancer treatment is highly individualised. An accurate diagnosis and staging assessment are essential before deciding whether surgery, chemotherapy, radiation therapy or a combination of treatments is appropriate.
If you or a loved one has been diagnosed with bone cancer, consult an oncology specialist to understand the diagnosis, treatment options and next steps based on the individual case.
Book an Oncology ConsultationMedical Disclaimer: The information provided on this page is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis or treatment. Bone cancer treatment varies from patient to patient. Diagnosis and treatment decisions should be made in consultation with a qualified oncology team after reviewing the individual's medical history, pathology and imaging.
Precision Oncology Clinic, the best Cancer Clinic in Bangalore, located in Vijayanagar. Book appointment!
©2024. All Rights Reserved. Precision Oncology Clinic
By HAAPS
Book Appointment